Table 1.
Strict Criteria | Equivocal Criteria | |||
---|---|---|---|---|
Prevalence | Rate* | 95% CI | Rate | 95% CI |
Overall** | 0.30 | (0.00, 0.72) | 0.33 | (0.00, 0.82) |
Male | 0.23 | (0.00, 0.63) | 0.24 | (0.00, 0.73) |
<40yr | 1.64 | (0.00, 0.63) | 1.64 | (0.00, 0.73) |
40–49yr | 0.03 | (0.00, 2.86) | 0.03 | (0.00, 2.87) |
50–59yr | 0.02 | (0.00, 0.22) | 0.03 | (0.00, 0.29) |
60–69yr | 0.07 | (0.00, 0.18) | 0.08 | (0.00, 0.28) |
70+ | 0.05 | (0.00, 0.53) | 0.08 | (0.00, 0.60) |
Female | 1.11 | (0.00, 5.09) | 1.23 | (0.00, 6.06) |
<40yr | 1.62 | (0.00, 7.04) | 1.69 | (0.00, 7.62) |
40–49yr | 0.89 | (0.00, 6.23) | 1.08 | (0.00, 7.67) |
50–59yr | 1.43 | (0.00, 4.66) | 1.59 | (0.00, 5.63) |
60–69yr | 0.36 | (0.00, 2.94) | 0.48 | (0.00, 3.92) |
70+ | 0.13 | (0.00, 1.12) | 0.22 | (0.00, 1.87) |
VHA; Veterans Health Affairs, IC/BPS; interstitial cystitis/bladder pain syndrome.
*Rate per 100 persons.
**By strict criteria, overall US Standardized rate was 0.87 (95% CI: 0.32,1.42) overall, 0.66 (95% CI: 0.44, 0.87) for men and 1.08 (95% CI: 0.03, 2.13) for women. By Equivocal criteria, overall US Standardized rate was 0.94 (95% CI: 0.32,1.56) overall, 0.67 (95% CI: 0.58, 0.75) for men and 1.20 (95% CI: 0.00, 2.39) for women.